Dr. Metz on Somatostatin Analogs and Emerging Agents in NETs Landscape
October 19th 2017David C. Metz, MD, PhD, associate chief for Clinical Affairs, Gastrointestinal Division, Penn Medicine, University of Pennsylvania, discusses the utility of somatostatin analogs and emerging agents in the landscape of neuroendocrine tumors (NETs).